Clinical Trials Browser

Phase 3 × Recruiting × Advanced Non-small Cell Lung Cancer × Clear all

NCT06452277 2026-05-18

SOHO-02

Phase 3 Recruiting

Advanced Non-small Cell Lung Cancer

NCT06043973 2023-09-21

Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance

Phase 3 Recruiting

Advanced Non-small Cell Lung Cancer